Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Thiolat

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Cytokine|July 16, 2014
Interleukin-35 gene therapy exacerbates experimental rheumatoid arthritis in miceA Thiolat, A Denys, M Petit, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 4, 2014
Reply: To PMID 24504799A Thiolat, J Biton, P Decker, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 8, 2014
Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritisA Thiolat, L Semerano, Y M Pers, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Cytokine|July 16, 2014
Interleukin-35 gene therapy exacerbates experimental rheumatoid arthritis in miceA Thiolat, A Denys, M Petit, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 4, 2014
Reply: To PMID 24504799A Thiolat, J Biton, P Decker, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 8, 2014
Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritisA Thiolat, L Semerano, Y M Pers, et al.
Pageof 1